Many experimental results indicated that IL-10-deficient mouse has susceptibility to IBD, and overexpression of IL-10 was related to good therapeutic effect of drugs for IBD (Zhou et al., 2004; Engelhardt and Grimbacher, 2014; Keubler et al., 2015). The gene discussed is IL10; the disease is inflammatory bowel disease.